Tumor genotype (Repugene Technology, Hangzhou, China) disclosed EGFR Exon19 c.2235-2249de p.E746-A750del with a mutant abundance of 21.7% while lack of expression of programmed death ligand 1. This evidence concerns the gene EGFR and neoplasm.